Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
about
Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesionsMagnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects.Modeling the effect of intra-voxel diffusion of contrast agent on the quantitative analysis of dynamic contrast enhanced magnetic resonance imaging.Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesionsBackground Parenchymal Enhancement of the Contralateral Normal Breast: Association with Tumor Response in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.US-localized diffuse optical tomography in breast cancer: comparison with pharmacokinetic parameters of DCE-MRI and with pathologic biomarkers.Metabolomics of Breast Cancer Using High-Resolution Magic Angle Spinning Magnetic Resonance Spectroscopy: Correlations with 18F-FDG Positron Emission Tomography-Computed Tomography, Dynamic Contrast-Enhanced and Diffusion-Weighted Imaging MRIThe Changing World of Breast Cancer: A Radiologist's Perspective.Dynamic Contrast-Enhanced MRI Perfusion Parameters as Imaging Biomarkers of Angiogenesis.Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer.Correlations Between DCE MRI and Histopathological Parameters in Head and Neck Squamous Cell Carcinoma.Dynamic contrast-enhanced MRI of gastric cancer: Correlation of the perfusion parameters with pathological prognostic factors.Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.Breast cancer molecular subtype classifier that incorporates MRI featuresAssessment of Aggressiveness of Breast Cancer Using Simultaneous 18F-FDG-PET and DCE-MRI: Preliminary Observation.Characteristics of quantitative perfusion parameters on dynamic contrast-enhanced MRI in mammographically occult breast cancer.Associations between tumor vascularization assessed by in vivo DCE-MRI and the presence of disseminated tumor cells in bone marrow in breast cancer patients at the time of diagnosis.Dynamic contrast-enhanced and diffusion-weighted MRI of estrogen receptor-positive invasive breast cancers: Associations between quantitative MR parameters and Ki-67 proliferation status.The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.Dynamic contrast enhanced-MRI in rectal cancer: Inter- and intraobserver reproducibility and the effect of slice selection on pharmacokinetic analysis.Retrospective analysis of the utility of multiparametric MRI for differentiating between benign and malignant breast lesions in women in China.DCE- and DW-MRI as early imaging biomarkers of treatment response in a preclinical model of triple negative breast cancer.Correlation between voxel-wise enhancement parameters on DCE-MRI and pathological prognostic factors in invasive breast cancers.Quantitative DCE-MRI for prediction of pathological complete response following neoadjuvant treatment for locally advanced breast cancer: the impact of breast cancer subtypes on the diagnostic accuracy.MRI features predictive of negative surgical margins in patients with HER2 overexpressing breast cancer undergoing breast conservation.Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.Prediction of low-risk breast cancer using quantitative DCE-MRI and its pathological basis.Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor.Can imaging kinetic parameters of dynamic contrast-enhanced magnetic resonance imaging be valuable in predicting clinicopathological prognostic factors of invasive breast cancer?PET/MR in invasive ductal breast cancer: correlation between imaging markers and histological phenotype.DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes.Prognostic aspects of dynamic contrast-enhanced magnetic resonance imaging in synchronous distant metastatic rectal cancer.Intravoxel incoherent motion MR imaging for breast lesions: comparison and correlation with pharmacokinetic evaluation from dynamic contrast-enhanced MR imaging.Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.Grading of pancreatic neuroendocrine neoplasms using pharmacokinetic parameters derived from dynamic contrast-enhanced MRI.A novel approach to monitoring the efficacy of anti-tumor treatments in animal models: combining functional MRI and texture analysisA radiomic nomogram based on an apparent diffusion coefficient map for differential diagnosis of suspicious breast findings
P2860
Q33599166-B213F5DE-047F-403F-8705-8E84872B75A7Q33690733-A6C2F362-EFCA-40CD-9AD0-08B6875DD6C0Q34282239-A524CDB9-7A3B-4E0F-8463-FB0DC7414C69Q35048378-ABF67755-A427-456B-A234-F3CF74A8540FQ35804271-A590E080-ACCC-4B71-801A-4888E8C757C3Q35911336-001AEE3D-2D6D-4D4F-BE1B-D77F8EE275B2Q36086056-93546542-9599-48DC-B5CC-D963BB1D3D5AQ36217490-3C50EBF2-09B7-45A5-A65B-C3DEA9D6A927Q36236333-6E343574-405F-4A1F-81AC-ED773E89CE55Q36271681-DD1F9535-6227-4977-9D9A-ACB454E27F2EQ37442942-2222573F-7E34-4A5D-93CD-4AFA523BD6F8Q38232035-3D2D813C-A552-4AAD-9815-FC902FF824B1Q38250247-3E988CB0-7F00-47F7-9F2B-60890986A72AQ38693206-D41A4625-4E11-4AA5-9D03-C234186C74D8Q38866273-F4C750C8-E748-40DE-89F9-43A5CC92125CQ38905724-17D9856D-0F12-4AA3-8455-BA585E41BE2FQ39262277-E55D4DB6-A9AC-4C54-950A-56C18DB55867Q39676450-7639F54C-6251-446D-8AD6-A98DB0F4EAE3Q41675215-B6D9129A-EDF5-4866-81C4-CB7F928E5210Q46017323-2396BC3F-B999-4283-BD50-4AC20F2EEB77Q47549197-14454D15-2A86-4BD1-B6C1-F47805F05417Q47670339-D6FF97ED-3B50-45F9-AB89-03B40DB534F9Q47921813-B142745B-9497-4311-BAAD-9C1EF7A00738Q48141719-35A101A8-B8E8-4ABD-B7BF-C5D58652A22CQ48266960-28A4934C-D9FF-46DD-BF69-E48176B84953Q48322318-D9C31C19-4A9E-496A-8380-96AD2484483FQ49188455-2D4669CF-4D2F-4B40-B729-672EE19B9855Q50054742-AB79B309-DEE8-4AC1-AB7A-AAC364ADB631Q50144009-A9299494-D55B-437A-B9B7-CA9BB4AFA574Q51135004-B4E12B52-8635-4383-9E1D-36B900283570Q51734273-BD2F444A-AA28-4212-8FEF-810AF2C8F9D2Q53034336-3B2D05CA-4D7D-445C-B0EF-0139A1A9D73CQ53196884-5673EC16-5AC0-46BE-B45C-4F62CDF2AB3AQ54387590-A4FCF457-40B7-48D5-BA53-2C101A0AB0A8Q55255348-4AF79336-2EAB-4BFE-9FBC-6AD0BD05F619Q58736677-84213C04-7038-44A8-A9B6-186B4B516A6CQ58804561-B2C59C70-C029-4BBA-86B9-7E07855811B3
P2860
Correlation of perfusion parameters on dynamic contrast-enhanced MRI with prognostic factors and subtypes of breast cancers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Correlation of perfusion param ...... nd subtypes of breast cancers.
@en
type
label
Correlation of perfusion param ...... nd subtypes of breast cancers.
@en
prefLabel
Correlation of perfusion param ...... nd subtypes of breast cancers.
@en
P2093
P2860
P356
P1476
Correlation of perfusion param ...... nd subtypes of breast cancers.
@en
P2093
Hye Ryoung Koo
Hyeonjin Kim
In Chan Song
Nariya Cho
Woo Kyung Moon
P2860
P304
P356
10.1002/JMRI.23635
P577
2012-03-05T00:00:00Z